Market Tracker

01/20 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

103.18
Delayed Data
As of Jan 20
 +1.92 / +1.90%
Today’s Change
82.06
Today|||52-Week Range
139.79
+1.55%
Year-to-Date

Today’s Trading

Previous close101.26
Today’s open102.27
Day’s range102.04 - 105.11
Volume396,581
Average volume (3 months)360,744
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+1,833.30%
Earnings growth (this year)+0.89%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio368.5
Price/Sales32.00
Price/Book8.67

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.01+0.07%
SAGESAGE Therapeutics In...+0.19+0.36%
ARRYArray Biopharma Inc+0.17+1.52%
MDCOMedicines Co-0.55-1.53%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)$1.31
Annual revenue (last year)$71.9M
Annual profit (last year)$229.8M
Net profit margin319.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts